Kokudo Norihiro, Takemura Nobuyuki, Hasegawa Kiyoshi, Takayama Tadatoshi, Kubo Shoji, Shimada Mitsuo, Nagano Hiroaki, Hatano Etsuro, Izumi Namiki, Kaneko Shuichi, Kudo Masatoshi, Iijima Hiroko, Genda Takuya, Tateishi Ryosuke, Torimura Takuji, Igaki Hiroshi, Kobayashi Satoshi, Sakurai Hideyuki, Murakami Takamichi, Watadani Takeyuki, Matsuyama Yutaka
The committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan.
Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6.
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.
日本肝脏学会依据循证医学方法,并部分参照推荐分级的评估、制定与评价系统,修订了《肝细胞癌临床实践指南》第四版,该指南于2017年10月以日语发布。本文特别参考监测、诊断及治疗算法,阐述了新的或经修订的推荐内容。